Immunogenicity and reactogenicity of yellow fever vaccine in people with HIV.
Journal Information
Full Title: AIDS
Abbreviation: AIDS
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Acquired Immunodeficiency Syndrome
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflicts of interest There are no conflicts of interest."
"L.E.C., L.A.B.C., B.G., S.W.C. conceived and designed the study. A.B.F., S.M.B.L., L.P., F.C., C.G., M.M., S.N., M.C.O.S., Y.S.M., A.S.A., N.S.A. contributed to the study implementation, data collection and laboratorial analysis. L.E.C., E.M., M.C., R.I.M., L.A.B.C. contributed to the statistical analysis and interpretation. E.M. and L.E.C. wrote the first draft and all authors reviewed and approved the final version of the report and the manuscript. This work was funded by National Council for Scientific and Technological Development – CNPq and by Presidência da Fundação Oswaldo Cruz/Vice Presidência de Pesquisa e Coleções Biológicas VPPCB/Fiocruz - Chamada CNPq/Fiocruz N° 16/2017- PROEP/PEC (# 420674/2017–9). This work was also supported by Instituto Nacional de Infectologia Evandro Chagas (INI/Fiocruz) and Coordenação de Vigilância em Saúde e Laboratórios de Referência (CVSLR) / FIOCRUZ/ MS. B.G. acknowledges funding from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) and Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ)."
"This study was approved by INI/Fiocruz Ethics Committee (CAAE: #67136517.9.0000.5262) and registered at Clinicaltrials.gov (NCT03132311). All participants provided written informed consent."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025